Table 1 main characteristics of 10 studies included in the meta-analysis
References | Inclusion interval | Country | Mean age (range) | Design | No. of patients (F/M) | No. of nodules | Magnetic strength | b-values (s/mm2) | Parameter (DWI, PET) | Reference test | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Ohno et al. [18] | 2015.09–2016.08 | Japan | 70.3 (53–84) | Prospective | 82 (30/52) | 88 | 3.0T | 1000 | ADC, SUVmax | His/Fol | |
Nomori et al. [19] | 2012.12–2014.03 | Japan | – | Retrospective | 77 (–/–) | 87 | 1.5T | 800 | SI-CR, SUV-CR | His/Fol | |
Ohba et al. [24] | 2007.10–2009.03 | Japan | – | Prospective | 58 (–/–) | 76 | 3.0T, 1.5T | 1000 | ADC, SUV-CR | His/Fol | |
Mori et al. [25] | 2006.02–2007.07 | Japan | 68 (20–80) | Retrospective | 104 (49/55) | 140 | 1.5T | 1000 | ADC, SUV-CR | His/Fol | |
Ohba et al. [8] | 2006.02–2007.12 | Japan | 68 (36–82) | Retrospective | 110 (54/56) | 124 | 1.5T | 1000 | ADC, SUV-CR | His/Fol | |
Zhang et al. [26] | 2010.09–2013.01 | Chineses | 59 (26–81) | Retrospective | 113 (46/67) | 108 | 3.0T | 1000 | ADC, SUVmax | His | |
Katsuo et al. [22] | 2009.05–2012.02 | Japan | 68.5 (37–87) | Prospective | 189 (65/124) | 189 | 1.5T | 800 | ADC, SUVmax | His/Fol | |
Kang et al. [21] | 2008.09–2009.06 | Chineses | 51 (39–78) | Retrospective | 26 (5/21) | 26 | 1.5T | 600 | ADC, SUVmax | His/Fol | |
Liu et al. [23] | 2016.01–2018.06 | Chineses | 64.6 (–) | Prospective | 36 (12/24) | 36 | 3.0T | Total | ADC, SUVmax | His | |
Selcuk et al. [20] | 2014–2017 | Turkey | 57.8 (36–85) | Prospective | 76 (16/60) | 74 | 1.5T | 500 | ADC, SUVmax | His | |